Clinical Trial Update: PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of PERT for exocrine pancreatic insufficiency in unresectable pancreatic cancer; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Insufficiency

Snippet

Sponsor: Massimo Raimondo, M.D. | Conditions: Pancreatic Insufficiency, Pancreatic Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-03-15